FIDELIS CAPITAL PARTNERS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1962755 TAMPA, FL

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$866,566

+$72,576 QoQ

Shares Held

6,859

+20.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#1,141

of 2,266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

FIDELIS CAPITAL PARTNERS, LLC holds $51,570,809 across 10 Drug Manufacturers - General names. GILD ranks #8 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	55,734	$14,154,763
2	LLY	ELI LILLY & Co	11,461	$13,746,668
3	ABBV	AbbVie Inc.	38,686	$9,734,945
4	MRK	Merck & Co., Inc.	51,693	$6,642,550
5	AMGN	Amgen Inc	8,119	$2,940,052
6	BMY	Bristol Myers Squibb Co	27,994	$1,613,014
7	PFE	Pfizer Inc	51,883	$1,249,342
8	GILD	Gilead Sciences, Inc. This page	6,859	$866,566

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$866,566	6,859	+20.4%	Shares	Sole	2026-08-13
2026-03-31	$793,990	5,697	+9.7%	Shares	Sole	2026-05-06
2025-12-31	$637,266	5,192	+4.1%	Shares	Sole	2026-02-09
2025-09-30	$553,446	4,986	-5.8%	Shares	Sole	2025-11-03
2025-06-30	$586,613	5,291	+12.2%	Shares	Sole	2025-08-07
2025-03-31	$528,427	4,716	+0.1%	Shares	Sole	2025-05-01
2024-12-31	$434,970	4,709	+4.8%	Shares	Sole	2025-02-06
2024-09-30	$376,776	4,494	+6.3%	Shares	Sole	2024-10-25
2024-06-30	$289,945	4,226	+39.7%	Shares	Sole	2024-08-13
2024-03-31	$221,581	3,025	+19.8%	Shares	Sole	2024-05-06
2023-12-31	$204,550	2,525	—	Shares	Sole	2024-01-31
No filing history on record for this holder in this stock.